AKM
Aspire Mining Limited
🇦🇺 ASX
⛏️ MINING
📈 HIGH PRICE GROWTH
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 22.14%
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
3
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Aspire Mining Ltd. is a mineral exploration and development company. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-02-06. The firm 100% owns the Ovoot Coking Coal Project, and 90% owns the Nuurstei Coking Coal Project, both located in Khuvsgul aimag of north-western Mongolia. The firm is primarily focused on developing the Ovoot Coking Coal Project to mine coking coal via open pit methods, beneficiate it onsite, transport it by truck to a Company-owned coal unloading and loading facility near Erdenet, and delivering it onward via rail to customers in China, Russia and beyond utilizing the existing trans-Mongolian rail network. The Ovoot Project area is located in north-western Mongolia and comprises mining license MV017098. The Nuurstei project comprises mining license MV-020941 and is capable of producing washed hard coking coal. The project is located approximately 10 kilometers (km) from Khuvsgul provincial capital of Moron and is approximately 160 km northeast of the Ovoot project.
📈 Performance
Price History
-43.27%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
0%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.29
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in AKM
3
📊 Total Capital Earnings
$2K
🔃 Average investment frequency
68 weeks
💵 Average investment amount
$2,381
⏰ Last time a customer invested in AKM
14 days
AKM investor breakdown
💵 Income of investors
More than 200k
150k - 200k
67%
100k - 150k
50k - 100k
Less than 50k
33%
👶 Age of investors
18 - 25
26 - 34
100%
35 - 90
🙋 Legal gender of investors
Female
67%
Male
33%
Pearlers who invest in AKM also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.82%
📊 Share price
$102.75 AUD
🇦🇺 AUSTRALIA
💸 FINANCIALS
🧱 MATERIALS
⛳️ DIVERSIFIED
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
12.24%
📊 Share price
$126.50 AUD
🌏 GLOBAL
🤖 TECHNOLOGY
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
ACDC.AX was created on 2018-08-30 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Battery ValueChain Index (the Index).
🙌 Performance (5Yr p.a)
13.68%
📊 Share price
$80.22 AUD
🤖 TECHNOLOGY
🏭 INDUSTRIALS
🇦🇺 EX AUSTRALIA
📈 HIGH PRICE GROWTH
Actinogen Medical Ltd. is a clinical stage Australian biotechnology company, which focuses on the development of novel treatments or cognitive impairment associated with neurological, psychiatric, and metabolic diseases due to raised cortisol. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-10-16. The firm is engaged in the development of a therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol. The firm is engaged in the development of its lead compound, Xanamem, as a therapy for Alzheimer’s Disease, Major Depressive Disorder, Fragile X Syndrome, and other neurological diseases where reducing cortisol inside brain cells could have a positive impact. Xanamem’s mechanism of action is to block the production of cortisol inside cells through the inhibition of the 11B-HSD1 enzyme in the brain. Xanamem is designed to get into the brain after it is absorbed in the intestines upon swallowing its capsule. The company has studied 11B-HSD1 inhibition by Xanamem in approximately 300 volunteers and patients. The firm conducts a series of Phase II studies in multiple diseases to further confirm and characterize Xanamem’s therapeutic potential.
🙌 Performance (5Yr p.a)
59.08%
📊 Share price
$0.03 AUD
🧬 BIOTECHNOLOGY
ROBO.AX was created on 2017-09-13 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the ROBO.AX Global Robotics and Automation Index (the Index)
🙌 Performance (5Yr p.a)
3.96%
📊 Share price
$71.16 AUD
🇦🇺 EX AUSTRALIA
🩺 HEALTH CARE
🤖 TECHNOLOGY
🏭 INDUSTRIALS
Want more shares? Try these...
AuKing Mining Ltd. engages in the acquisition, development, and exploration of mineral properties. The company is headquartered in Brisbane, Queensland. The company went IPO on 2007-10-29. The firm has six projects in Tanzania, four of which are prospective for uranium (Manyoni, Mkuju, Itigi and Magaga) and the other two are prospective for copper (Mpanda and Karema). The Manyoni/Itigi project is situated nearby the central Tanzanian city of Dodoma and on the railway line that runs to the port city of Dar es Salaam. The Mkuju project is situated in southern Tanzania. The Mpanda/Karema project is a prospective copper area in western Tanzania that was the subject of historic mining operations but largely untouched by modern exploration methods. The firm holds the Koongie Park Copper Zinc Project in Western Australia's Halls Creek Region, which hosts a Joint Ore Reserves Committee resource and is neighbored by several significant mining and development operations, including Nicholson's Gold Mine and Savannah Nickel Mine.
🙌 Performance (5Yr p.a)
50.60%
📊 Share price
$0.01 AUD
⛏️ MINING
Akora Resources Ltd. engages in the exploration and development of iron ore projects in Madagascar. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-12-15. The firm is engaged in the exploration and development of the Bekisopa, Satrokala, Tratramarina and Ambodilafa Projects, all iron ore prospects in Madagascar. The company holds some 308 square kilometers (km2) of tenements across these four prospective exploration areas. The Company’s flagship Bekisopa Iron Ore Project has a 194.7 million tons (mt) Inferred JORC Resource. The Bekisopa project is located 220km from the West Coast and is accessed from Antananarivo. The Satrokala Project is located around 20km to the south-west of Bekisopa. The Tratramarina Project is located only 16km from the ocean with a potential port/transhipping location south of Mahanoro near the mouth of the Mangoro River. The Ambodilafa Project is located approximately 45km from the coastal town of Nosy Varika and 75 km southwest of Mahanoro, which is a natural transhipping port location. Its geographical segments include Australia and Madagascar.
📊 Share price
$0.09 AUD
⛏️ MINING
Alexium International Group Ltd. engages in the provision of developing chemical solutions. The company is headquartered in Perth, Western Australia. The Company’s principal activities include research and development in consultation with end clients; obtaining patents in relation to new products developed; and commercialization and sales of the products. The Company’s product solutions include thermal regulation solutions and flame-retardant solutions. Its thermal regulation solutions include Alexicool, BioCool, Eclipsys and DelCool. Alexicool is a phase change material (PCM)-based cooling product for textile and foam applications. BioCool is a biobased microencapsulated PCM (mPCM) line of products for the bedding industry. Eclipsys is a perpetual cooling technology for textile and foam-based products. Its flame-retardant solution includes Alexiflam and Alexiguard. The Alexiflam is a flame-retardant technology for use in mattress applications.
🙌 Performance (5Yr p.a)
-18.46%
📊 Share price
$0.01 AUD
🧪 CHEMICALS
Academies Australasia Group Ltd. engages in the provision of training and education services. The company is headquartered in Sydney, New South Wales. The firm offers a range of recognized courses at different levels, such as bachelor’s degrees, vocational education and training (VET) certificates, diplomas and advanced diplomas, English language, senior high school, and Singapore government school preparatory courses. The company comprises approximately 18 separately licensed colleges operating in New South Wales, Queensland, South Australia, Victoria and Western Australia in Australia, and overseas in Singapore. The company offers over 180 qualifications in many disciplines and has served over 100,000 students from 130 countries. The Company’s colleges include Academy of English (English Language Intensive Courses for Overseas Students), Australian International High School (Senior High School), Academies Australasia Institute (Vocational), Australian College of Technology (Vocational), Benchmark College (Vocational), Clarendon Business College (Vocational) and other.
🙌 Performance (5Yr p.a)
-15.97%
📊 Share price
$0.13 AUD
🛍️ CONSUMER